Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694433 · ClinicalTrials.gov registry record · Phase 2
"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01694433 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 66 participants.
The verdict
NCT01694433, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene, but contains no active ingredients.
Interventions
- DRUG Placebo
- DRUG Calcipotriene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-01-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694433
The ClinicalTrials.gov registry entry for NCT01694433 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01694433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01694433 about?
NCT01694433 is a clinical study titled ""Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"". The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene...
What is the current status of trial NCT01694433?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2013-02. Estimated completion is 2014-01-09.
What interventions are being tested in trial NCT01694433?
The interventions under investigation include: Placebo (DRUG), Calcipotriene (DRUG).
Who is sponsoring clinical trial NCT01694433?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.